Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B.
about
Recognition and Regulation of T Cells by NK CellsA Practical Model Evaluating Antiviral Cytokines by Natural Killer Cells in Treatment Naïve Patients with Chronic Hepatitis B Virus Infection.Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo.T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System.Hepatitis B: treatment choice and monitoring for response and resistance.Host-virus interactions in hepatitis B and hepatitis C infection.Chronic hepatitis B surface antigen seroclearance-related immune factors.Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.Functional restoration of CD56(bright) NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B.Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogue: A Randomized, Controlled Trial (PEGON).Exosomes: multitask cargo carriers modulating innate immunity to viruses.Circulating NK cells and their subsets in Behçet's disease.Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation.Unconventional T cells in chronic hepatitis B patients on long-term suppressive therapy with tenofovir followed by a Peg-IFN add-on strategy: A randomized study.Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?Innate and Adaptive Cell Populations Driving Inflammation in Dry Eye Disease
P2860
Q26742166-412B4DF3-B817-4D3B-9267-5B74F5A25141Q33919051-10827814-5BD1-47C8-8BF6-86496F742AD2Q36093940-F72DA044-D951-49C4-ACFB-B276AA1AEFB2Q37598020-CB175CD1-DE63-4EDC-AB71-887C0A19147AQ38707903-170D31BF-F6FA-4A28-83CC-874BCF3F5B2DQ38740771-DF31446E-3293-48A5-82A2-33BAACAEA072Q38809744-26B922A4-99DA-4A93-8199-924346BD9690Q40066224-9A9F9AA7-398F-4917-B0EB-BBD246121FE5Q40150197-5A2080B5-0323-424F-8BFB-4426644A581FQ40280592-BE57038B-7356-4BDF-938C-DE4215DC5AF0Q40644709-5C1F6C10-1BA9-4837-AE27-818912D03E8BQ42097602-A49A4891-6E80-419F-8D94-1ED84FE684B2Q47557330-44867694-2600-4C76-9D12-F7569490A524Q47593872-BC621ABB-039A-43FF-927D-56CD7D410406Q54217690-72E71B12-8ADC-46A1-8FC5-59DD1AB2A182Q58787880-AE1EEF58-FBAF-4D6C-A68E-88D122E506F0
P2860
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Natural killer cell phenotype ...... ents with chronic hepatitis B.
@en
type
label
Natural killer cell phenotype ...... ents with chronic hepatitis B.
@en
prefLabel
Natural killer cell phenotype ...... ents with chronic hepatitis B.
@en
P2093
P2860
P50
P356
P1433
P1476
Natural killer cell phenotype ...... ients with chronic hepatitis B
@en
P2093
Andrea Vecchi
Arianna Alfieri
Federica Invernizzi
Giuseppe Pedrazzi
Lavinia Talamona
Maria Cristina Cavallo
Marzia Rossi
Massimo Colombo
Tiziana Giuberti
P2860
P304
P356
10.1002/HEP.28155
P407
P577
2015-10-29T00:00:00Z